LOW-DENSITY LIPOPROTEIN METABOLISM IN THE NEPHROTIC SYNDROME

被引:87
作者
WARWICK, GL [1 ]
CASLAKE, MJ [1 ]
BOULTONJONES, JM [1 ]
DAGEN, M [1 ]
PACKARD, CJ [1 ]
SHEPHERD, J [1 ]
机构
[1] GLASGOW ROYAL INFIRM,DEPT PATHOL BIOCHEM,GLASGOW G4 0SF,SCOTLAND
来源
METABOLISM-CLINICAL AND EXPERIMENTAL | 1990年 / 39卷 / 02期
关键词
D O I
10.1016/0026-0495(90)90074-M
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Hyperlipidemia is a consistent feature of the nephrotic syndrome. In this study, low-density lipoprotein (LDL) metabolism has been investigated in nine patients with nephrotic syndrome and varying degrees of proteinuria. In subjects with moderate proteinuria (less than 10 g/d), total plasma cholesterol values were elevated to approximately 160% of normal due mainly to an increase in circulating LDL cholesterol. Metabolic studies showed that a defect in LDL clearance via the receptor pathway was responsible for its accumulation. The total amount of LDL apolipoprotein catabolized by this mechanism was only 55% of the value seen in controls; 60% more LDL was channelled into alternative, receptor-independent, catabolic pathways. Heavier proteinuria was associated with substantial increases in plasma triglyceride and very-low-density lipoprotein (VLDL) levels. The defect in LDL catabolism was aggravated by oversynthesis of the lipoprotein, which expanded the plasma LDL pool to 250% of normal. These observations indicate that the hyperlipidemia of the nephrotic syndrome is multifactorial in origin. The altered catabolism of LDL may be important in predisposing these subjects to premature atherosclerosis. © 1990.
引用
收藏
页码:187 / 192
页数:6
相关论文
共 37 条
[1]   THE HYPERLIPIDEMIA OF THE NEPHROTIC SYNDROME - RELATION TO PLASMA-ALBUMIN CONCENTRATION, ONCOTIC PRESSURE, AND VISCOSITY [J].
APPEL, GB ;
BLUM, CB ;
CHIEN, S ;
KUNIS, CL ;
APPEL, AS .
NEW ENGLAND JOURNAL OF MEDICINE, 1985, 312 (24) :1544-1548
[2]   SERUM LIPID AND LIPOPROTEIN ALTERATIONS IN NEPHROSIS [J].
BAXTER, JH ;
GOODMAN, HC ;
HAVEL, RJ .
JOURNAL OF CLINICAL INVESTIGATION, 1960, 39 (03) :455-465
[3]  
BERMAN M, 1974, US PHS PUBLICATION, V1703
[4]  
BERNARD DB, 1982, CONTEMP ISS NEPHROL, V9, P85
[5]   METABOLIC STUDIES IN FAMILIAL HYPERCHOLESTEROLEMIA - EVIDENCE FOR A GENE-DOSAGE EFFECT INVIVO [J].
BILHEIMER, DW ;
STONE, NJ ;
GRUNDY, SM .
JOURNAL OF CLINICAL INVESTIGATION, 1979, 64 (02) :524-533
[6]   HYPERLIPEMIA IN UNTREATED NEPHROTIC SYNDROME, INCREASED PRODUCTION OR DECREASED REMOVAL [J].
CHAN, MK ;
PERSAUD, JW ;
RAMDIAL, L ;
VARGHESE, Z ;
SWENY, P ;
MOORHEAD, JF .
CLINICA CHIMICA ACTA, 1981, 117 (03) :317-323
[7]   THE MECHANISM OF HYPERLIPEMIA IN NEPHROTIC SYNDROME - ROLE OF LOW ALBUMIN AND THE LCAT REACTION [J].
COHEN, SL ;
CRAMP, DG ;
LEWIS, AD ;
TICKNER, TR .
CLINICA CHIMICA ACTA, 1980, 104 (03) :393-400
[8]   CATABOLISM OF VERY LOW-DENSITY LIPOPROTEINS IN EXPERIMENTAL NEPHROSIS [J].
GARBER, DW ;
GOTTLIEB, BA ;
MARSH, JB ;
SPARKS, CE .
JOURNAL OF CLINICAL INVESTIGATION, 1984, 74 (04) :1375-1383
[9]   RELATIONSHIP AMONG CONCENTRATIONS OF SERUM-LIPOPROTEINS AND CHANGES IN THEIR CHEMICAL COMPOSITION IN PATIENTS WITH UNTREATED NEPHROTIC SYNDROME [J].
GHERARDI, E ;
ROTA, E ;
CALANDRA, S ;
GENOVA, R ;
TAMBORINO, A .
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 1977, 7 (06) :563-570
[10]   STUDIES ON THE METABOLISM OF PLASMA PROTEINS IN THE NEPHROTIC SYNDROME .2. LIPOPROTEINS [J].
GITLIN, D ;
CORNWELL, DG ;
NAKASATO, D ;
ONCLEY, JL ;
HUGHES, WL ;
JANEWAY, CA .
JOURNAL OF CLINICAL INVESTIGATION, 1958, 37 (02) :172-184